Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
1999-02-05
Product name:
CELEXA 10 MG
DIN:
02239606
Product Monograph/Veterinary Labelling:
Date:
2024-02-19
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
LUNDBECK CANADA INC
2600 Alfred-Nobel, Suite 400
St-Laurent
Quebec
Canada
H4S 0A9
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.04.20
Anatomical Therapeutic Chemical (ATC): See footnote 4
N06AB04 CITALOPRAM
Active ingredient group (AIG) number:See footnote5
0136243003
| Active ingredient(s) | Strength |
|---|---|
| CITALOPRAM (CITALOPRAM HYDROBROMIDE) | 10 MG |